|
MRPL30 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.38269999999863E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.622000E-03 |
| Normal-vs-Stage2 |
5.447600E-02 |
| Normal-vs-Stage3 |
6.51150000030576E-07 |
| Normal-vs-Stage4 |
3.48859999999007E-06 |
| Stage1-vs-Stage2 |
6.298800E-01 |
| Stage1-vs-Stage3 |
1.341320E-03 |
| Stage1-vs-Stage4 |
2.883400E-03 |
| Stage2-vs-Stage3 |
1.371630E-01 |
| Stage2-vs-Stage4 |
1.375190E-01 |
| Stage3-vs-Stage4 |
9.189000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.91558999999009E-05 |
| Normal-vs-AfricanAmerican |
2.09330000000563E-07 |
| Normal-vs-Asian |
4.853400E-01 |
| Caucasian-vs-AfricanAmerican |
2.809800E-02 |
| Caucasian-vs-Asian |
5.364400E-01 |
| AfricanAmerican-vs-Asian |
8.205600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.18849999958459E-07 |
| Normal-vs-Female |
9.684000E-03 |
| Male-vs-Female |
2.868400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.622400E-04 |
| Normal-vs-Age(41-60Yrs) |
3.774900E-04 |
| Normal-vs-Age(61-80Yrs) |
4.45650000000519E-05 |
| Normal-vs-Age(81-100Yrs) |
3.208000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.185950E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.887230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.445600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.832800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.778400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.306400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.727770E-01 |
| Normal-vs-Grade 2 |
3.276500E-02 |
| Normal-vs-Grade 3 |
1.27910000002895E-06 |
| Normal-vs-Grade 4 |
1.16169999953009E-07 |
| Grade 1-vs-Grade 2 |
8.596800E-01 |
| Grade 1-vs-Grade 3 |
3.679000E-01 |
| Grade 1-vs-Grade 4 |
1.821620E-02 |
| Grade 2-vs-Grade 3 |
6.543400E-03 |
| Grade 2-vs-Grade 4 |
1.415290E-04 |
| Grade 3-vs-Grade 4 |
3.936400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.486400E-01 |
| Normal-vs-ccB subtype |
1.25849999976779E-07 |
| ccA subtype-vs-ccB subtype |
3.4026999999881E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.648200E-04 |
| Normal-vs-N1 |
8.902300E-02 |
| N0-vs-N1 |
4.537600E-01 |
|
|
